Cargando…

Risk stratification in childhood hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Norrish, Gabrielle, Kaski, Juan Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Magdi Yacoub Heart Foundation 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209434/ https://www.ncbi.nlm.nih.gov/pubmed/30393636 http://dx.doi.org/10.21542/gcsp.2018.24

Ejemplares similares

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
por: Norrish, Gabrielle, et al.
Publicado: (2021)

A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2019)

Outcomes following general anaesthesia in children with hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2019)

Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making
por: Norrish, Gabrielle, et al.
Publicado: (2023)

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
por: Lorenzini, Massimiliano, et al.
Publicado: (2020)

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Friedreich’s ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study
por: Norrish, Gabrielle, et al.
Publicado: (2022)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom
por: Norrish, Gabrielle, et al.
Publicado: (2019)

Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
por: Du, Darson, et al.
Publicado: (2022)

Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives: Evidence for a Change in Paradigm
por: Norrish, Gabrielle, et al.
Publicado: (2019)

Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy
por: Santoro, Francesco, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Clinical and Genetic Screening for Hypertrophic Cardiomyopathy in Paediatric Relatives: Changing Paradigms in Clinical Practice
por: Lawley, Claire M., et al.
Publicado: (2023)

The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2020)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Orthostatic Blood Pressure Test for Risk Stratification in Patients with Hypertrophic Cardiomyopathy
por: Münch, Julia, et al.
Publicado: (2015)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Risk Stratification in Hypertrophic Cardiomyopathy. Insights from Genetic Analysis and Cardiopulmonary Exercise Testing
por: Magrì, Damiano, et al.
Publicado: (2020)

Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy
por: Liu, Jie, et al.
Publicado: (2022)

Becker muscular dystrophy associated with sarcomeric hypertrophic cardiomyopathy in a paediatric patient: a case report
por: Dolader, Paola, et al.
Publicado: (2019)

Left Ventricular Mechanical Dispersion for the Better Risk Stratification of Patients With Hypertrophic Cardiomyopathy: Is It Possible?
por: Mohsenibadalabadi, Reza, et al.
Publicado: (2021)

Cardiac magnetic resonance as a risk re-stratification tool in apical hypertrophic cardiomyopathy
por: Larriva, Ana María, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2022)

Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach
por: Arsenos, Petros, et al.
Publicado: (2022)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Doesch, Christina, et al.
Publicado: (2017)

Does papillary muscle free strain has predictive value in risk stratification of patients with hypertrophic cardiomyopathy?
por: Koyuncu, Atilla, et al.
Publicado: (2023)

Risk stratification in cardiomyopathy
por: Sinagra, Gianfranco, et al.
Publicado: (2020)

Alcohol septal ablation in hypertrophic cardiomyopathy
por: Mateo, Juan José Santos, et al.
Publicado: (2018)

Clinical presentation and long‐term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study
por: Norrish, Gabrielle, et al.
Publicado: (2021)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
por: Marston, Nicholas A, et al.
Publicado: (2021)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
por: Dong, Yan, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy risk stratification based on clinical or dynamic electrophysiological features: two sides of the same coin
por: Sau, Arunashis, et al.
Publicado: (2023)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings
por: Soler, Rafaela, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n80jt2vq55gn4jil7ndf3jlrra